Qube Research & Technologies (QRT)
TNYA icon

Qube Research & Technologies (QRT)’s Tenaya Therapeutics TNYA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-127,232
Closed -$665K – 4716
2024
Q1 		$665K Buy
+127,232
New +$609K ﹤0.01% 2382
2023
Q4 		– Sell
-109,660
Closed -$280K – 4734
2023
Q3 		$280K Buy
+109,660
New +$459K ﹤0.01% 2280

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TNYA Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Tenaya Therapeutics (TNYA) in Q2 2024, closing a stake of 127,232 shares — an estimated $665K sold.

Qube Research & Technologies (QRT) first reported a position in TNYA in Q3 2023 and held it in 2 quarters. The position peaked at $665K in Q1 2024. 96 funds tracked by Wall St. Rank hold TNYA as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Tenaya Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 127,232 Tenaya Therapeutics shares in Q2 2024, an estimated $665K.
  • Qube Research & Technologies (QRT) first reported a position in Tenaya Therapeutics in Q3 2023 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Tenaya Therapeutics position peaked at $665K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.